Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy - Reuters

Reuters | June 2, 2025, 10:22 a.m. | Original
Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy Reuters
Mexico announces second placement of bonds worth some $9.3 billion - TradingView BofA expects Amazon to save billions in costs through robotics, hikes PO - TradingView